Skip to main content
Erschienen in: Clinical Rheumatology 3/2016

01.03.2016 | Original Article

Novel markers of endothelial dysfunction and inflammation in Behçet’s disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio

verfasst von: Murat Yuksel, Abdulkadir Yildiz, Mustafa Oylumlu, Fatih Mehmet Turkcu, Mehmet Zihni Bilik, Aysun Ekinci, Bilal Elbey, Ebru Tekbas, Sait Alan

Erschienen in: Clinical Rheumatology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

The etiology of Behçet’s disease (BD) has not been fully elucidated. However, immunological and environmental factors, endothelial dysfunction (ED), and genetic susceptibility have been proposed to play a role. In this study, we aimed to evaluate epicardial fat thickness (EFT) together with serum asymmetric dimethylarginine (ADMA), carotid intima media thickness (CIMT), and neutrophil-to-lymphocyte ratio (NLR) in BD patients with ocular involvement. Thirty-six ocular BD patients (17 active and 19 inactive ocular involvement), and 35 age and sex-matched healthy controls were enrolled to this cross-sectional study. All patients underwent examinations with transthoracic echocardiography and carotid Doppler ultrasound. Serum ADMA levels, CIMT, EFT, and NLR were compared between groups, and their association with disease activity was evaluated. Behçet’s disease patients had higher WBC counts, neutrophil counts, NLR, CIMT, EFT values, and serum ADMA levels than do healthy controls. The other biochemical, hematological, and echocardiographic parameters were comparable between the two groups. Behçet’s disease duration was positively correlated with EFT and CIMT. Multivariate logistic regression analysis revealed that increased serum ADMA concentration and CIMT are independently associated with BD. Neutrophil counts, NLR, and serum ADMA level were higher, and lymphocyte count was lower in patients with active ocular BD compared to those of inactive ocular BD group. Carotid intima media thickness, serum ADMA level, EFT, and NLR were increased in ocular BD patients compared to healthy subjects. In addition, both serum ADMA level and NLR were associated with disease activity of ocular involvement. Increase in disease duration was associated with increase in CIMT and EFT which suggests that anatomical changes occur in time during the disease course. Increased CIMT, serum ADMA level, EFT, and NLR may provide new clues about the role of ED and inflammation in the etiopathogenesis of BD.
Literatur
1.
Zurück zum Zitat Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behcet’s disease. N Engl J Med 341(17):1284–1291CrossRefPubMed Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behcet’s disease. N Engl J Med 341(17):1284–1291CrossRefPubMed
2.
Zurück zum Zitat Verity DH, Wallace GR, Vaughan RW, Stanford MR (2003) Behcet’s disease: from Hippocrates to the third millennium. Br J Ophthalmol 87(9):1175–1183CrossRefPubMedPubMedCentral Verity DH, Wallace GR, Vaughan RW, Stanford MR (2003) Behcet’s disease: from Hippocrates to the third millennium. Br J Ophthalmol 87(9):1175–1183CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Kapsimali VD, Kanakis MA, Vaiopoulos GA, Kaklamanis PG (2010) Etiopathogenesis of Behcet’s disease with emphasis on the role of immunological aberrations. Clin Rheumatol 29(11):1211–1216CrossRefPubMed Kapsimali VD, Kanakis MA, Vaiopoulos GA, Kaklamanis PG (2010) Etiopathogenesis of Behcet’s disease with emphasis on the role of immunological aberrations. Clin Rheumatol 29(11):1211–1216CrossRefPubMed
4.
Zurück zum Zitat Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M et al (2000) Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 102(9):994–999CrossRefPubMed Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M et al (2000) Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 102(9):994–999CrossRefPubMed
5.
Zurück zum Zitat Maldonado FJ, Miralles Jde H, Aguilar EM, Gonzalez AF, Garcia JR, Garcia FA (2009) Relationship between noninvasively measured endothelial function and peripheral arterial disease. Angiology 60(6):725–731CrossRefPubMed Maldonado FJ, Miralles Jde H, Aguilar EM, Gonzalez AF, Garcia JR, Garcia FA (2009) Relationship between noninvasively measured endothelial function and peripheral arterial disease. Angiology 60(6):725–731CrossRefPubMed
6.
Zurück zum Zitat Yurdakul S, Erdemir VA, Yildirimturk O, Gurel MS, Aytekin S (2012) Evaluation of endothelial functions in patients with Behcet’s disease without overt vascular involvement. Turk Kardiyoloji Dernegi arsivi Turk Kardiyoloji Derneginin yayin organidir 40(6):518–522CrossRefPubMed Yurdakul S, Erdemir VA, Yildirimturk O, Gurel MS, Aytekin S (2012) Evaluation of endothelial functions in patients with Behcet’s disease without overt vascular involvement. Turk Kardiyoloji Dernegi arsivi Turk Kardiyoloji Derneginin yayin organidir 40(6):518–522CrossRefPubMed
7.
Zurück zum Zitat Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Ronnemaa T et al (2004) Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. Circulation 110(18):2918–2923CrossRefPubMed Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Ronnemaa T et al (2004) Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. Circulation 110(18):2918–2923CrossRefPubMed
8.
Zurück zum Zitat Boger RH, Maas R, Schulze F, Schwedhelm E (2005) Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality. Clin Chemi Lab Med: CCLM / FESCC 43(10):1124–1129 Boger RH, Maas R, Schulze F, Schwedhelm E (2005) Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality. Clin Chemi Lab Med: CCLM / FESCC 43(10):1124–1129
9.
Zurück zum Zitat Perticone F, Sciacqua A, Maio R, Perticone M, Maas R, Boger RH et al (2005) Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 46(3):518–523CrossRefPubMed Perticone F, Sciacqua A, Maio R, Perticone M, Maas R, Boger RH et al (2005) Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 46(3):518–523CrossRefPubMed
10.
Zurück zum Zitat Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H et al (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108(20):2460–2466CrossRefPubMed Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H et al (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108(20):2460–2466CrossRefPubMed
11.
Zurück zum Zitat Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG et al (2007) Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 116(11):1234–1241CrossRefPubMed Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG et al (2007) Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 116(11):1234–1241CrossRefPubMed
12.
Zurück zum Zitat Teijeira-Fernandez E, Eiras S, Grigorian-Shamagian L, Fernandez A, Adrio B, Gonzalez-Juanatey JR (2008) Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension. J Hum Hypertens 22(12):856–863CrossRefPubMed Teijeira-Fernandez E, Eiras S, Grigorian-Shamagian L, Fernandez A, Adrio B, Gonzalez-Juanatey JR (2008) Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension. J Hum Hypertens 22(12):856–863CrossRefPubMed
13.
Zurück zum Zitat Ozturk S, Erdem A, Ozlu MF, Ayhan S, Erdem K, Ozyasar M et al (2013) Assessment of the neutrophil to lymphocyte ratio in young patients with acute coronary syndromes. Turk Kardiyoloji Dernegi arsivi Turk Kardiyoloji Derneginin yayin organidir 41(4):284–289CrossRefPubMed Ozturk S, Erdem A, Ozlu MF, Ayhan S, Erdem K, Ozyasar M et al (2013) Assessment of the neutrophil to lymphocyte ratio in young patients with acute coronary syndromes. Turk Kardiyoloji Dernegi arsivi Turk Kardiyoloji Derneginin yayin organidir 41(4):284–289CrossRefPubMed
14.
Zurück zum Zitat Demir M (2013) The relationship between neutrophil lymphocyte ratio and non-dipper hypertension. Clin Exp Hypertens 35(8):570–573CrossRefPubMed Demir M (2013) The relationship between neutrophil lymphocyte ratio and non-dipper hypertension. Clin Exp Hypertens 35(8):570–573CrossRefPubMed
15.
Zurück zum Zitat No Authors (1990) Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet 335(8697):1078–1080. No Authors (1990) Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet 335(8697):1078–1080.
16.
Zurück zum Zitat Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A et al (2003) Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 88(11):5163–5168CrossRefPubMed Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A et al (2003) Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 88(11):5163–5168CrossRefPubMed
17.
Zurück zum Zitat MacAllister RJ, Fickling SA, Whitley GS, Vallance P (1994) Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. Br J Pharmacol 112(1):43–48CrossRefPubMedPubMedCentral MacAllister RJ, Fickling SA, Whitley GS, Vallance P (1994) Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. Br J Pharmacol 112(1):43–48CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Chambers JC, Haskard DO, Kooner JS (2001) Vascular endothelial function and oxidative stress mechanisms in patients with Behcet’s syndrome. J Am Coll Cardiol 37(2):517–520CrossRefPubMed Chambers JC, Haskard DO, Kooner JS (2001) Vascular endothelial function and oxidative stress mechanisms in patients with Behcet’s syndrome. J Am Coll Cardiol 37(2):517–520CrossRefPubMed
19.
Zurück zum Zitat Onur E, Kabaroglu C, Inanir I, Var A, Guvenc Y, Gunay O et al (2011) Oxidative stress impairs endothelial nitric oxide levels in Behcets’ disease. Cutan Ocul Toxicol 30(3):217–220CrossRefPubMed Onur E, Kabaroglu C, Inanir I, Var A, Guvenc Y, Gunay O et al (2011) Oxidative stress impairs endothelial nitric oxide levels in Behcets’ disease. Cutan Ocul Toxicol 30(3):217–220CrossRefPubMed
20.
Zurück zum Zitat Buldanlioglu S, Turkmen S, Ayabakan HB, Yenice N, Vardar M, Dogan S et al (2005) Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behcet’s disease. Br J Dermatol 153(3):526–530CrossRefPubMed Buldanlioglu S, Turkmen S, Ayabakan HB, Yenice N, Vardar M, Dogan S et al (2005) Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behcet’s disease. Br J Dermatol 153(3):526–530CrossRefPubMed
21.
Zurück zum Zitat Sahin M, Arslan C, Naziroglu M, Tunc SE, Demirci M, Sutcu R et al (2006) Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet’s disease. Ann Clin Lab Sci 36(4):449–454PubMed Sahin M, Arslan C, Naziroglu M, Tunc SE, Demirci M, Sutcu R et al (2006) Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet’s disease. Ann Clin Lab Sci 36(4):449–454PubMed
22.
Zurück zum Zitat Franceschelli S, Ferrone A, Pesce M, Riccioni G, Speranza L (2013) Biological functional relevance of asymmetric dimethylarginine (ADMA) in cardiovascular disease. Int J Mol Sci 14(12):24412–24421CrossRefPubMedPubMedCentral Franceschelli S, Ferrone A, Pesce M, Riccioni G, Speranza L (2013) Biological functional relevance of asymmetric dimethylarginine (ADMA) in cardiovascular disease. Int J Mol Sci 14(12):24412–24421CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Yilmaz MI, Demirkaya E, Acikel C, Saldir M, Akar S, Cayci T et al (2014) Endothelial function in patients with familial Mediterranean fever-related amyloidosis and association with cardiovascular events. Rheumatology 53(11):2002–2008 Yilmaz MI, Demirkaya E, Acikel C, Saldir M, Akar S, Cayci T et al (2014) Endothelial function in patients with familial Mediterranean fever-related amyloidosis and association with cardiovascular events. Rheumatology 53(11):2002–2008
24.
Zurück zum Zitat Lu TM, Chung MY, Lin MW, Hsu CP, Lin SJ (2011) Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography. Int J Cardiol 153(2):135–140CrossRefPubMed Lu TM, Chung MY, Lin MW, Hsu CP, Lin SJ (2011) Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography. Int J Cardiol 153(2):135–140CrossRefPubMed
25.
Zurück zum Zitat Gunebakmaz O, Duran M, Karakaya E, Tanrikulu E, Akpek M, Ergin A et al (2013) Increased serum asymmetric dimethylarginine level is an independent predictor of contrast-induced nephropathy. Turk Kardiyoloji Dernegi arsivi Turk Kardiyoloji Derneginin yayin organidir 41(7):581–588CrossRefPubMed Gunebakmaz O, Duran M, Karakaya E, Tanrikulu E, Akpek M, Ergin A et al (2013) Increased serum asymmetric dimethylarginine level is an independent predictor of contrast-induced nephropathy. Turk Kardiyoloji Dernegi arsivi Turk Kardiyoloji Derneginin yayin organidir 41(7):581–588CrossRefPubMed
26.
Zurück zum Zitat Onat A, Hergenc G, Can G, Karabulut A (2008) Serum asymmetric dimethylarginine levels among Turks: association with metabolic syndrome in women and tendency to decrease in smokers. Turk Kardiyoloji Dernegi arsivi Turk Kardiyoloji Derneginin yayin organidir 36(1):7–13PubMed Onat A, Hergenc G, Can G, Karabulut A (2008) Serum asymmetric dimethylarginine levels among Turks: association with metabolic syndrome in women and tendency to decrease in smokers. Turk Kardiyoloji Dernegi arsivi Turk Kardiyoloji Derneginin yayin organidir 36(1):7–13PubMed
27.
Zurück zum Zitat Celik M, Cerrah S, Arabul M, Akalin A (2014) Relation of asymmetric dimethylarginine levels to macrovascular disease and inflammation markers in type 2 diabetic patients. J Diabetes Res 2014:139215CrossRefPubMedPubMedCentral Celik M, Cerrah S, Arabul M, Akalin A (2014) Relation of asymmetric dimethylarginine levels to macrovascular disease and inflammation markers in type 2 diabetic patients. J Diabetes Res 2014:139215CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M (2002) Increased nitric oxide production in patients with Behcet’s disease: is it a new activity marker? J Am Acad Dermatol 46(1):50–54CrossRefPubMed Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M (2002) Increased nitric oxide production in patients with Behcet’s disease: is it a new activity marker? J Am Acad Dermatol 46(1):50–54CrossRefPubMed
29.
Zurück zum Zitat Kiraz S, Ertenli I, Calguneri M, Ozturk MA, Haznedaroglu IC, Altun B et al (2001) Interactions of nitric oxide and superoxide dismutase in Behcet’s disease. Clin Exp Rheumatol 19(5 Suppl 24):S25–S29PubMed Kiraz S, Ertenli I, Calguneri M, Ozturk MA, Haznedaroglu IC, Altun B et al (2001) Interactions of nitric oxide and superoxide dismutase in Behcet’s disease. Clin Exp Rheumatol 19(5 Suppl 24):S25–S29PubMed
30.
Zurück zum Zitat Ozuguz P, Karabulut AA, Tulmac M, Kisa U, Kocak M, Gunduz O (2014) Markers of endothelial dysfunction and evaluation of vascular reactivity tests in Behcet Disease. Angiology 65(10):937–943 Ozuguz P, Karabulut AA, Tulmac M, Kisa U, Kocak M, Gunduz O (2014) Markers of endothelial dysfunction and evaluation of vascular reactivity tests in Behcet Disease. Angiology 65(10):937–943
31.
Zurück zum Zitat Kayikcioglu M, Aksu K, Hasdemir C, Keser G, Turgan N, Kultursay H et al (2006) Endothelial functions in Behcet’s disease. Rheumatol Int 26(4):304–308CrossRefPubMed Kayikcioglu M, Aksu K, Hasdemir C, Keser G, Turgan N, Kultursay H et al (2006) Endothelial functions in Behcet’s disease. Rheumatol Int 26(4):304–308CrossRefPubMed
32.
Zurück zum Zitat Ulusoy RE, Karabudak O, Kilicaslan F, Kirilmaz A, Us MH, Cebeci BS (2008) Noninvasive assessment of impaired endothelial dysfunction in mucocutaneous Behcet’s disease. Rheumatol Int 28(7):617–621CrossRefPubMed Ulusoy RE, Karabudak O, Kilicaslan F, Kirilmaz A, Us MH, Cebeci BS (2008) Noninvasive assessment of impaired endothelial dysfunction in mucocutaneous Behcet’s disease. Rheumatol Int 28(7):617–621CrossRefPubMed
33.
Zurück zum Zitat Alan S, Ulgen MS, Akdeniz S, Alan B, Toprak N (2004) Intima-media thickness and arterial distensibility in Behcet’s disease. Angiology 55(4):413–419CrossRefPubMed Alan S, Ulgen MS, Akdeniz S, Alan B, Toprak N (2004) Intima-media thickness and arterial distensibility in Behcet’s disease. Angiology 55(4):413–419CrossRefPubMed
34.
Zurück zum Zitat Hong SN, Park JC, Yoon NS, Lee SR, Kim KH, Hong YJ et al (2008) Carotid artery intima-media thickness in Behcet’s disease patients without significant cardiovascular involvement. Korean J Intern Med 23(2):87–93CrossRefPubMedPubMedCentral Hong SN, Park JC, Yoon NS, Lee SR, Kim KH, Hong YJ et al (2008) Carotid artery intima-media thickness in Behcet’s disease patients without significant cardiovascular involvement. Korean J Intern Med 23(2):87–93CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340(1):14–22CrossRefPubMed O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340(1):14–22CrossRefPubMed
36.
Zurück zum Zitat Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR et al (1997) Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol 146(6):483–494CrossRefPubMed Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR et al (1997) Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol 146(6):483–494CrossRefPubMed
37.
Zurück zum Zitat Iacobellis G, Barbaro G (2008) The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm Metab Res 40(7):442–445CrossRefPubMed Iacobellis G, Barbaro G (2008) The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm Metab Res 40(7):442–445CrossRefPubMed
38.
Zurück zum Zitat Kaya H, Ertas F, Oylumlu M, Bilik MZ, Yildiz A, Yuksel M et al (2013) Relation of epicardial fat thickness and brachial flow-mediated vasodilation with coronary artery disease. J Cardiol 62(6):343–347CrossRefPubMed Kaya H, Ertas F, Oylumlu M, Bilik MZ, Yildiz A, Yuksel M et al (2013) Relation of epicardial fat thickness and brachial flow-mediated vasodilation with coronary artery disease. J Cardiol 62(6):343–347CrossRefPubMed
39.
Zurück zum Zitat Oylumlu M, Ozler A, Yildiz A, Oylumlu M, Acet H, Polat N et al (2014) New inflammatory markers in pre-eclampsia: echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio. Clin Exp Hypertens 36(7):503–507 Oylumlu M, Ozler A, Yildiz A, Oylumlu M, Acet H, Polat N et al (2014) New inflammatory markers in pre-eclampsia: echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio. Clin Exp Hypertens 36(7):503–507
40.
Zurück zum Zitat Kim BJ, Kim BS, Kang JH (2013) Echocardiographic epicardial fat thickness is associated with arterial stiffness. Int J Cardiol 167(5):2234–2238CrossRefPubMed Kim BJ, Kim BS, Kang JH (2013) Echocardiographic epicardial fat thickness is associated with arterial stiffness. Int J Cardiol 167(5):2234–2238CrossRefPubMed
Metadaten
Titel
Novel markers of endothelial dysfunction and inflammation in Behçet’s disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio
verfasst von
Murat Yuksel
Abdulkadir Yildiz
Mustafa Oylumlu
Fatih Mehmet Turkcu
Mehmet Zihni Bilik
Aysun Ekinci
Bilal Elbey
Ebru Tekbas
Sait Alan
Publikationsdatum
01.03.2016
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 3/2016
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-2907-0

Weitere Artikel der Ausgabe 3/2016

Clinical Rheumatology 3/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.